Skip to main content

ADVERTISEMENT

comparative effectiveness

01/19/2016
JCP Editors
Shorter radiation courses followed by consolidation chemotherapy before surgery may be an effective treatment option for rectal cancer patients. High volume bouts of chemoradiation are often used before surgery in...
Shorter radiation courses followed by consolidation chemotherapy before surgery may be an effective treatment option for rectal cancer patients. High volume bouts of chemoradiation are often used before surgery in...
...
01/19/2016
Journal of Clinical Pathways
Research in Review
01/18/2016
JCP Editors
Dacomitinib may be comparable to erlotinib in treating non-small cell lung cancer (NSCLC), specifically in patients that are positive for the epidermal growth factor receptor (EGFR) mutation. Dacomitinib, an...
Dacomitinib may be comparable to erlotinib in treating non-small cell lung cancer (NSCLC), specifically in patients that are positive for the epidermal growth factor receptor (EGFR) mutation. Dacomitinib, an...
...
01/18/2016
Journal of Clinical Pathways
01/12/2016
JCP Editors
Cabozantinib improves progression-free survival in patients with advanced renal cell carcinoma, according to an ongoing clinical trial comparing the drug with everolimus, an immunosuppressant that is the current...
Cabozantinib improves progression-free survival in patients with advanced renal cell carcinoma, according to an ongoing clinical trial comparing the drug with everolimus, an immunosuppressant that is the current...
...
01/12/2016
Journal of Clinical Pathways
Counterpoint
12/14/2015
Joan S. McClure, MS
Al B. Benson III, MD, FACP, FASCO
Before the relative value of a drug can be determined, one must first consider how value is defined by the patient. Cancer care is expensive, and evaluating costs in cancer care is complex. Drug costs are only part...
Before the relative value of a drug can be determined, one must first consider how value is defined by the patient. Cancer care is expensive, and evaluating costs in cancer care is complex. Drug costs are only part...
Before...
12/14/2015
Journal of Clinical Pathways
Research in Review
12/07/2015
JCP Editors
A phase 3 head-to-head trial comparing the effectiveness of Kyprolis (carfilzomib) in combination with dexamethasone has shown better outcomes in patients with multiple myeloma than the current standard of care,...
A phase 3 head-to-head trial comparing the effectiveness of Kyprolis (carfilzomib) in combination with dexamethasone has shown better outcomes in patients with multiple myeloma than the current standard of care,...
A...
12/07/2015
Journal of Clinical Pathways
Research in Review
11/04/2015
JCP Editors
A study first presented at the Annual Meeting of the American Radium Society (May 2–5) in Kauai, HI, and now published in the Journal of Clinical Oncology, may help to better define the role of chemoradiotherapy...
A study first presented at the Annual Meeting of the American Radium Society (May 2–5) in Kauai, HI, and now published in the Journal of Clinical Oncology, may help to better define the role of chemoradiotherapy...
A...
11/04/2015
Journal of Clinical Pathways